Common Contracts

AMENDED AND RESTATED CREDIT AGREEMENT dated as of May 2, 2019, by and among AERIE PHARMACEUTICALS, INC., as Borrower CERTAIN SUBSIDIARIES OF THE BORROWER, as Guarantors, VARIOUS LENDERS, and DEERFIELD PRIVATE DESIGN FUND III, L.P., as Agent...

Credit Agreement • May 3rd, 2019 • Aerie Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York

• Contract Type
  Credit Agreement
• Filed
  May 3rd, 2019
• Company
  Aerie Pharmaceuticals Inc
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

AMENDED AND RESTATED CREDIT AGREEMENT (this “Agreement”), dated as of May 2, 2019, by and among Aerie Pharmaceuticals, Inc., a Delaware corporation (the “Borrower”), the other Loan Parties (as defined below) party hereto from time to time, the lenders set forth on the signature page of this Agreement (together with their successors and assigns, the “Lenders”), Deerfield Private Design Fund III, L.P., as agent for itself and the Lenders (in such capacity, together with its successors and assigns in such capacity, “Agent,” and, together with the Lenders, the Borrower and the other Loan Parties party hereto, the “Parties”).

CREDIT AGREEMENT dated as of July 23, 2018, by and among AERIE PHARMACEUTICALS, INC., as Borrower CERTAIN SUBSIDIARIES OF THE BORROWER, as Guarantors, VARIOUS LENDERS, and DEERFIELD PRIVATE DESIGN FUND III, L.P., as Agent $100,000,000 Subsequent...

Credit Agreement • July 23rd, 2018 • Aerie Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York

• Contract Type
  Credit Agreement
• Filed
  July 23rd, 2018
• Company
  Aerie Pharmaceuticals Inc
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

CREDIT AGREEMENT (this “Agreement”), dated as of July 23, 2018, by and among Aerie Pharmaceuticals, Inc., a Delaware corporation (the “Borrower”), the other Loan Parties (as defined below) party hereto from time to time, the lenders set forth on the signature page of this Agreement (together with their successors and assigns, the “Lenders”), Deerfield Private Design Fund III, L.P., as agent for itself and the Lenders (in such capacity, together with its successors and assigns in such capacity, “Agent,” and, together with the Lenders, the Borrower and the other Loan Parties party hereto, the “Parties”).